JP2022551580A5 - - Google Patents
Info
- Publication number
- JP2022551580A5 JP2022551580A5 JP2022520229A JP2022520229A JP2022551580A5 JP 2022551580 A5 JP2022551580 A5 JP 2022551580A5 JP 2022520229 A JP2022520229 A JP 2022520229A JP 2022520229 A JP2022520229 A JP 2022520229A JP 2022551580 A5 JP2022551580 A5 JP 2022551580A5
- Authority
- JP
- Japan
- Prior art keywords
- alkylene
- alkyl
- aryl
- optionally substituted
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025150734A JP2025183335A (ja) | 2019-10-04 | 2025-09-11 | 巣状分節性糸球体硬化症および糖尿病性腎症のバイオマーカーに基づく処置 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962910758P | 2019-10-04 | 2019-10-04 | |
| US62/910,758 | 2019-10-04 | ||
| PCT/US2020/054282 WO2021067946A1 (en) | 2019-10-04 | 2020-10-05 | Biomarker-based treatment of focal segmental glomerulosclerosis and diabetic kidney disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025150734A Division JP2025183335A (ja) | 2019-10-04 | 2025-09-11 | 巣状分節性糸球体硬化症および糖尿病性腎症のバイオマーカーに基づく処置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022551580A JP2022551580A (ja) | 2022-12-12 |
| JP2022551580A5 true JP2022551580A5 (https=) | 2023-10-12 |
Family
ID=75337492
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520229A Pending JP2022551580A (ja) | 2019-10-04 | 2020-10-05 | 巣状分節性糸球体硬化症および糖尿病性腎症のバイオマーカーに基づく処置 |
| JP2025150734A Pending JP2025183335A (ja) | 2019-10-04 | 2025-09-11 | 巣状分節性糸球体硬化症および糖尿病性腎症のバイオマーカーに基づく処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025150734A Pending JP2025183335A (ja) | 2019-10-04 | 2025-09-11 | 巣状分節性糸球体硬化症および糖尿病性腎症のバイオマーカーに基づく処置 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240091303A1 (https=) |
| EP (1) | EP4037680A4 (https=) |
| JP (2) | JP2022551580A (https=) |
| KR (1) | KR20220079907A (https=) |
| AU (1) | AU2020357178A1 (https=) |
| CA (1) | CA3156814A1 (https=) |
| IL (1) | IL291903A (https=) |
| MX (1) | MX2022004049A (https=) |
| PH (1) | PH12022550818A1 (https=) |
| WO (1) | WO2021067946A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA71645A (fr) * | 2018-09-18 | 2025-05-30 | Goldfinch Bio, Inc. | Pyridazinones et leurs procédés d'utilisation |
| CN115927202A (zh) * | 2023-01-10 | 2023-04-07 | 北京爱思益普生物科技股份有限公司 | 一种trpc5突变细胞株及其构建方法和应用 |
| WO2024164818A1 (zh) * | 2023-02-08 | 2024-08-15 | 中国科学院上海药物研究所 | 黄嘌呤类化合物及其用途 |
| CN116919965B (zh) * | 2023-05-24 | 2024-05-17 | 徐州医科大学 | 一种trpml1特异性小分子抑制剂ml-si3的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8633233B2 (en) * | 2008-08-06 | 2014-01-21 | Hydra Biosciences, Inc. | Methods and compositions for treating anxiety |
| JP5795311B2 (ja) * | 2009-07-15 | 2015-10-14 | ネステク ソシエテ アノニム | 抗体ベースのアレイを使用する胃癌療法のための薬物選択 |
| US20110135574A1 (en) * | 2009-11-16 | 2011-06-09 | Anna Greka | Methods of treating kidney disease |
| JO3470B1 (ar) * | 2012-10-08 | 2020-07-05 | Merck Sharp & Dohme | مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv |
| DK3652176T3 (da) * | 2017-07-11 | 2022-01-17 | Boehringer Ingelheim Int | Substituerede xanthinderivater |
| WO2019028309A1 (en) * | 2017-08-04 | 2019-02-07 | Goldfinch Bio, Inc. | AZAINDOLES AND THEIR METHODS OF USE |
| WO2019028308A1 (en) * | 2017-08-04 | 2019-02-07 | Goldfinch Bio, Inc. | BENZIMIDAZOLES AND AZA-BENZIMIDAZOLES AND METHODS OF USE |
| US11370769B2 (en) * | 2017-09-07 | 2022-06-28 | Board Of Regents Of The University Of Nebraska | TRPC5 inhibitors and methods of using same |
| EP3684364A4 (en) * | 2017-09-18 | 2021-06-02 | Goldfinch Bio, Inc. | PYRIDAZINONE AND METHOD OF USE THEREOF |
| CA3093084A1 (en) * | 2018-03-05 | 2019-09-12 | Goldfinch Bio, Inc. | Imidazodiazepinediones and methods of use thereof |
| MA71645A (fr) * | 2018-09-18 | 2025-05-30 | Goldfinch Bio, Inc. | Pyridazinones et leurs procédés d'utilisation |
| WO2020206623A1 (en) * | 2019-04-10 | 2020-10-15 | Goldfinch Bio, Inc. | Crystal forms |
-
2020
- 2020-10-05 JP JP2022520229A patent/JP2022551580A/ja active Pending
- 2020-10-05 IL IL291903A patent/IL291903A/en unknown
- 2020-10-05 EP EP20871404.8A patent/EP4037680A4/en active Pending
- 2020-10-05 AU AU2020357178A patent/AU2020357178A1/en active Pending
- 2020-10-05 WO PCT/US2020/054282 patent/WO2021067946A1/en not_active Ceased
- 2020-10-05 MX MX2022004049A patent/MX2022004049A/es unknown
- 2020-10-05 KR KR1020227015035A patent/KR20220079907A/ko active Pending
- 2020-10-05 US US17/766,492 patent/US20240091303A1/en active Pending
- 2020-10-05 CA CA3156814A patent/CA3156814A1/en active Pending
- 2020-10-05 PH PH1/2022/550818A patent/PH12022550818A1/en unknown
-
2025
- 2025-09-11 JP JP2025150734A patent/JP2025183335A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022551580A5 (https=) | ||
| JP6400196B2 (ja) | ピリド［３，４−ｄ］ピリミジン誘導体及びその薬学的に許容される塩 | |
| AU2011272149B2 (en) | 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors | |
| AU2002242065B2 (en) | Antagonists of MCP-1 function and methods of use thereof | |
| US9206199B2 (en) | Inhibitors of the renal outer medullary potassium channel | |
| RU2240322C2 (ru) | Производные нафтиридина и содержащая их фармацевтическая композиция | |
| CN114748622B (zh) | P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd | |
| JP2022526818A5 (https=) | ||
| JP2014521751A (ja) | 腎髄質外層カリウムチャンネルの阻害薬 | |
| WO2015113990A1 (en) | Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection | |
| CN105143221A (zh) | 用于治疗炎性障碍的化合物及其药物组合物 | |
| JP2005516954A (ja) | １−アルキル−１−アゾニアビシクロ［２．２．２］オクタンカルバメート誘導体およびムスカリンレセプターアンタゴニストとしてのそれらの使用 | |
| ZA200608176B (en) | Carboline derivatives useful in the inhibition of angiogenesis | |
| CN104520288A (zh) | 作为ccr9拮抗剂的吡唑-1-基苯磺酰胺 | |
| EP3707142B1 (en) | Pyrrolopyrazine derivatives as alpha v integrin inhibitors | |
| JP2005525323A5 (https=) | ||
| JP2024517016A (ja) | Ｌｐａ受容体アンタゴニスト及びそれらの使用 | |
| EP4408529A1 (en) | Imidazopyridazine il-17 inhibitor compounds | |
| JP2019522628A5 (https=) | ||
| JP2023513599A (ja) | Ｊａｋキナーゼ関連疾患の治療のための薬物の調製におけるｊａｋ阻害剤の使用 | |
| AU2022405082A1 (en) | Lpa receptor antagonists and uses thereof | |
| JP2008524252A (ja) | Ｃｎｓ障害の処置のためのテトラヒドロイソキノリン化合物 | |
| KR102408814B1 (ko) | 루푸스를 치료하기 위한 화합물 및 방법 | |
| JP2007500676A5 (https=) | ||
| JP2021516225A5 (https=) |